Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease

表观遗传学 免疫学 生物 癸他滨 免疫系统 癌症研究 基因表达 DNA甲基化 遗传学 基因
作者
Haodong Ding,Yuwei Li,Maoxin Fang,Jiaojiao Chen,Liu Li-pin,Zhigang Lu,Jia Hou,Min Luo
出处
期刊:The Journal of Allergy and Clinical Immunology [Elsevier BV]
卷期号:151 (6): 1622-1633.e10 被引量:4
标识
DOI:10.1016/j.jaci.2023.04.003
摘要

Background X-linked MAGT1 deficiency with increased susceptibility to Epstein-Barr virus infection and N-linked glycosylation defect (XMEN) disease is a rare combined immunodeficiency caused by loss-of-function mutations in the magnesium transporter 1 (MAGT1) gene. MAGT1 deficiency impairs magnesium transport and the N-linked glycosylation of a panel of proteins, which subsequently abolishes the expression of key immune receptors such as natural killer group 2, member D (aka NKG2D). These effects induce immune system abnormalities, chronic Epstein-Barr virus infection, and neoplasia. Recent research shows that MAGT1 and tumor candidate suppressor 3 (TUSC3) share high sequence and functional similarity. Objective We sought to investigate the feasibility of activating TUSC3 expression to provide a potential therapeutic strategy for XMEN disease. Methods The expression profiles of MAGT1 and TUSC3 were analyzed using multiple databases, real-time quantitative PCR, and Western blot. The effects of decitabine and panobinostat on the regulation of TUSC3 expression were explored in both MAGT1 knockout (KO)/patient-derived lymphocytes and MAGT1 KO hepatocytes. Results Although TUSC3 is widely expressed, it is undetectable specifically in the immune system and liver, consistent with the main diseased tissues in patients with XMEN disease. CRISPR/Cas9-mediated KO of MAGT1 in the NKL cell line successfully mimicked the phenotypes of XMEN patient–derived lymphocytes, and exogenous expression of TUSC3 rescued the deficiencies in KO NKL cells. Using this in vitro model, we identified 2 epigenetic drugs, decitabine and panobinostat, by screening. Combination treatment using these 2 drugs significantly upregulated TUSC3 expression and rescued the immune and liver abnormalities. Conclusions Epigenetic activation of TUSC3 expression constitutes an effective therapeutic strategy for XMEN disease. X-linked MAGT1 deficiency with increased susceptibility to Epstein-Barr virus infection and N-linked glycosylation defect (XMEN) disease is a rare combined immunodeficiency caused by loss-of-function mutations in the magnesium transporter 1 (MAGT1) gene. MAGT1 deficiency impairs magnesium transport and the N-linked glycosylation of a panel of proteins, which subsequently abolishes the expression of key immune receptors such as natural killer group 2, member D (aka NKG2D). These effects induce immune system abnormalities, chronic Epstein-Barr virus infection, and neoplasia. Recent research shows that MAGT1 and tumor candidate suppressor 3 (TUSC3) share high sequence and functional similarity. We sought to investigate the feasibility of activating TUSC3 expression to provide a potential therapeutic strategy for XMEN disease. The expression profiles of MAGT1 and TUSC3 were analyzed using multiple databases, real-time quantitative PCR, and Western blot. The effects of decitabine and panobinostat on the regulation of TUSC3 expression were explored in both MAGT1 knockout (KO)/patient-derived lymphocytes and MAGT1 KO hepatocytes. Although TUSC3 is widely expressed, it is undetectable specifically in the immune system and liver, consistent with the main diseased tissues in patients with XMEN disease. CRISPR/Cas9-mediated KO of MAGT1 in the NKL cell line successfully mimicked the phenotypes of XMEN patient–derived lymphocytes, and exogenous expression of TUSC3 rescued the deficiencies in KO NKL cells. Using this in vitro model, we identified 2 epigenetic drugs, decitabine and panobinostat, by screening. Combination treatment using these 2 drugs significantly upregulated TUSC3 expression and rescued the immune and liver abnormalities. Epigenetic activation of TUSC3 expression constitutes an effective therapeutic strategy for XMEN disease.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
果123完成签到 ,获得积分10
1秒前
1秒前
1秒前
ZZY完成签到,获得积分10
1秒前
2秒前
Lucas的应助被huayu采纳,获得10
2秒前
2秒前
4秒前
华仔的应助被王业美少一横咯采纳,获得10
4秒前
AliceBaker272发布了新的文献求助40
4秒前
5秒前
CMJ完成签到,获得积分10
5秒前
zh完成签到,获得积分10
6秒前
6秒前
Harry完成签到 ,获得积分10
6秒前
tingi完成签到,获得积分10
6秒前
6秒前
DW的应助被单身的盼雁采纳,获得10
7秒前
noobmaster发布了新的文献求助10
7秒前
jsw发布了新的文献求助10
7秒前
8秒前
半棵橘子发布了新的文献求助10
9秒前
9秒前
Jasper的应助被爱笑的鹏涛采纳,获得10
9秒前
一口一个完成签到,获得积分10
10秒前
candice0202发布了新的文献求助10
10秒前
星辰大海的应助被追寻的沛白采纳,获得20
10秒前
10秒前
10秒前
大洪水关注了科研通微信公众号
10秒前
Zeage完成签到,获得积分10
10秒前
Dora完成签到,获得积分10
10秒前
思源的应助被xhq的大暨南采纳,获得10
11秒前
molihuakai的应助被耳朵儿歌采纳,获得30
11秒前
12秒前
dalin完成签到 ,获得积分10
12秒前
12秒前
pyj完成签到,获得积分20
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177404
求助须知:如何正确求助?哪些是违规求助? 9568297
关于积分的说明 21798595
捐赠科研通 7772027
什么是DOI,文献DOI怎么找? 3432346
关于科研通互助平台的介绍 2556564
邀请新用户注册赠送积分活动 2477863